Reuters logo
BRIEF-Acrux says co and Eli Lilly and Co agreed to terminate licensing agreement for Axiron
September 6, 2017 / 1:08 AM / 14 days ago

BRIEF-Acrux says co and Eli Lilly and Co agreed to terminate licensing agreement for Axiron

Sept 6 (Reuters) - Acrux Ltd

* Acrux and Eli Lilly and Company have mutually agreed to terminate their licensing agreement for Axiron

* Termination of license in US is effective immediately and termination of license outside US will be effective 90 days thereafter

* Global rights to product will revert to Acrux. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below